Diabetes affects an estimated 30.3 million people in the United States and is the seventh leading cause of death. Diabetes can affect many parts of the body and is associated with serious complications, such as heart disease and stroke, blindness, kidney failure, and lower limb amputation. In addition to increasing the risk for these complications, diabetes also doubles the risk for many forms of cancer, some forms of dementia, hearing loss, erectile dysfunction, urinary incontinence, and many other common diseases.
- Type 1 diabetes affects approximately 5 percent of adults and the majority of children and youth with diagnosed diabetes.
- Type 2 diabetes is the most common form of the disease, accounting for about 90 to 95 percent of diagnosed diabetes cases in U.S. adults. Type 2 diabetes is also increasingly being diagnosed in children and adolescents, and disproportionately affects minority youth.
- Prediabetes affects an estimated 84.1 million adults in the United States. Those with prediabetes are at high risk of developing type 2 diabetes.
- Gestational diabetes affects a significant proportion of pregnant women. In addition to placing the mother and child at risk for complications during childbirth, gestational diabetes increases the risk for eventual type 2 diabetes for both mother and child.
The NIDDK supports basic, clinical, and translational research to combat diabetes and its associated complications. For example, NIDDK researchers are:
- studying genetic and environmental factors that contribute to the development and progression of diabetes;
- studying ways to preserve insulin-producing cells of the pancreas;
- identifying new methods to improve blood glucose monitoring and insulin delivery in type 1 diabetes;
- examining behavioral approaches to prevent type 2 diabetes and to enhance diabetes self-management;
- conducting clinical trials testing new prevention and treatment strategies for diabetes and its complications, such as a trial comparing different type 2 diabetes medications and trials testing ways to prevent type 1 diabetes in relatives of people with the disease; and
- uncovering the fundamental cellular and molecular pathways underlying development of diabetes and its complications to develop new approaches to prevention and management.
The NIDDK also administers the Special Statutory Funding Program for Type 1 Diabetes Research, which is a special appropriation dedicated to supporting research on type 1 diabetes and its complications. More information on the Program and the research it supports is available on the Type 1 Diabetes Research Special Statutory Funding Program website.
In addition, NIDDK has congressional authorization for the National Diabetes Information Clearinghouse. The Clearinghouse responds to questions and provides health information about diabetes to people with diabetes and to their families, health professionals, and the public. The National Diabetes Education Program (NDEP) aims to improve the treatment and outcomes for people with diabetes, promote early diagnosis, and prevent or delay the onset of type 2 diabetes.
Research Updates and News
- NIH publishes the largest genomic study on type 2 diabetes in sub-Saharan African populations
- Drug delays type 1 diabetes in people at high risk
- Improvements in insulin release wane after treatment stops in adults with early type 2 diabetes
- NIH-funded trial finds vitamin D does not prevent type 2 diabetes in people at high risk
- Early weight-loss surgery may improve type 2 diabetes, blood pressure outcomes
Select Landmark Studies
What We Do
To achieve its mission, NIDDK supports, conducts, coordinates, and plans research. NIDDK also provides data and samples from NIDDK-funded studies and explains research findings to health professionals and the public.
NIDDK invests in basic, clinical and translational research and training at colleges, universities and other institutions.
- Bioengineering, Biotechnology, and Imaging as applied to Diabetes, Metabolic, and Endocrine Diseases
- Clinical Research in Type 1 Diabetes
- Clinical Research in Type 2 Diabetes
- Diabetes and Metabolism HIV/AIDS
- Diabetes Genetics and Genomics
- Diabetes, Endocrine, and Metabolic Disease Translational Research
- Diabetes: Treatment, Prevention, and Complications
NIDDK investigators conduct biomedical research and training in the Institute's laboratories and clinical facilities in Maryland and Arizona.
- Diabetes, Endocrinology, and Obesity Branch
- Genetics of Development and Disease Branch
- Laboratory of Biochemistry and Genetics
- Laboratory of Biological Modeling
- Laboratory of Bioorganic Chemistry
- Laboratory of Cell and Molecular Biology
Coordinate & Plan Research
NIDDK takes multiple approaches to research planning and priority setting.
Meetings & Workshops
- Precision Medicine in Pancreatic Disease: Knowledge Gaps and Research Opportunities
- New PI Workshop 2019
- 2019 Mid-Atlantic Diabetes and Obesity Research Symposium
- Sensory Nutrition and Disease Workshop
Strategic Plans & Reports
- NIDDK Recent Advances & Emerging Opportunities 2019
- Diabetes in America, 3rd Edition
- Special Statutory Funding Program for Type 1 Diabetes Research: Progress Report
- Special Statutory Funding Program for Type 1 Diabetes Research: Evaluation Report
- DMICC: Coordinating the Federal Investment in Diabetes Programs To Improve the Health of Americans
Provide Access to Research Resources
NIDDK makes publicly supported resources, data sets, and studies available to researchers.View all Research Resources
Provide Health Information
NIDDK provides patient education information, practice tools for diagnosis and treatment, and statistics.